Navigation Links
New treatment for receding gums: No pain, lots of gain
Date:7/1/2009

BOSTON (July 1, 2009, 7 a.m. ET) Tufts dental researchers conducted a three-year follow-up study that examined the stability of a treatment option for receding gums and found that complete root coverage the goal of the surgery had been maintained. This specific tissue regeneration application, developed at Tufts, reduces the considerable pain and recovery time of gum grafting surgery. The case study of six patients is published in the July 2009 issue of the Journal of Periodontology.

"Patients have a less invasive treatment option for receding gums and we now have evidence to support the stability of this relatively painless procedure. Instead of leaving the dental office with stitches in the roof of their mouth, a patient leaves with a small bandage on the arm that can be removed in an hour," said Terrence Griffin, DMD, associate professor, chair of the department of periodontology, and director of postdoctoral periodontology at Tufts University School of Dental Medicine in Boston.

"One of our previous research studies showed that all of the post-operative bleeding and most of the post-operative pain were related to the gum tissue removed from the roof of the mouth for use as a graft," he continued.

Traditional gum grafting surgery requires surgically excising tissue from the roof of the mouth (the palate) to replace the gum tissue lost around the teeth. Unfortunately, removing tissue from the roof of the mouth extends recovery time and is a major source of patients' discomfort or pain. According to the American Academy of Periodontology, periodontal disease is the primary cause of tooth loss in adults aged 35 and older. Periodontal disease includes gum recession, also called gingival recession, which can result in tooth root decay and tooth loss.

The new tissue regeneration application from Tufts uses platelet concentrate gel applied to a collagen membrane as the graft instead of using tissue from the roof of th
'/>"/>

Contact: Siobhan E. Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration
2. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
3. Holistic Skin Contouring Treatment Now Offered by Renowned Surgeon - The Results Are Simply Amazing
4. Even After Death, Heart Attack Treatment May Not End
5. Measurements fail to identify TB patients who could benefit from shorter treatment course
6. Women with cystic fibrosis can have safe and successful fertility treatment
7. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
8. Nonsurgical Treatment May Ease Rotator Cuff Injury
9. New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause
10. Rotator cuff treatment provides immediate tendonitis relief
11. Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...NSA new three-drug combination has shown in a phas...ve regimen" in the treatment of patients newly dia...ood cells in bone marrow, say researchers from Dan...r better were seen in all of the 66 patients treat...tudy, with 74 percent having a "very good partial ...
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Jeff Merkley (D-OR) for his lead...cts, including the authority to crack down on toba...
...ng is a Statement of Matthew L. Myers President, C...://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO...uds U.S. Senator Sherrod Brown (D-OH) for his lead...cts, including the authority to crack down on toba...
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Christopher Dodd (D-CT) for his ...roducts, including the authority to crack down on ...
...hore University HealthSystem Researcher reports in... Evanston, IL (Vocus) May 20, 2009 -- A... authored by David J. Winchester , FACS, M.D., Ch... nodes may not need a radical lymph node surgery. ...
...alance, Inc. (Nasdaq: SMBL ) today held its Annu... , Smart Balance Chairman and CEO Stephen Hughes ... and growth plans for the future. "Over the past ...es said. "We are excited as ever about the future...
...iation of Flight Attendants-CWA (AFA-CWA) today te...ose after a recent public health emergency and the...use of Representatives Subcommittee on Aviation co...elieve that we must be given the tools and ability...
Other Medicine News:Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 2Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 3Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 2Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 3Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 2Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 3Health News:Breast Cancer Patients May be Spared Additional Surgery 2Health News:Breast Cancer Patients May be Spared Additional Surgery 3Health News:Association of Flight Attendants-CWA Testifies on Emergency Planning After Recent Flu Outbreak 2
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 1Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 3ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 1ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 1PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 3
...d Acetaldehyde Levels in Subset of,Subjects with I..., Nov. 11 Raptor,Pharmaceuticals Corp. ("Raptor" ...y announced positive results in its Phase IIa stud...th ALDH2 deficiency, or ethanol,intolerance, as th...ogram.,Convivia(TM) is Raptor,s proprietary oral f...
...es patient screening for enrollment, SOUTH SAN FR...nc. (Nasdaq: RIGL ) today announced that the prev...ial of R788 (fostamatinib,disodium), the company,s...vember 2008 issue of Arthritis and Rheumatism. The...tis with a syk kinase inhibitor: A,twelve-week, ra...
Other Medicine Technology:Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 2Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 3Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 4Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 5Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 2Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: